Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul-Sep;12(3):289-294.
doi: 10.4103/jpbs.JPBS_233_19. Epub 2020 Jul 18.

Pharmacists' warfarin therapy knowledge and counseling practices in the Eastern Province, Saudi Arabia: A cross-sectional study

Ahmed Adel Mohamed  1 , Marwah E Alnewais  1 , Yasir A Ibrahim  1 , Mohammad F Zaitoun  2
Affiliations

Pharmacists' warfarin therapy knowledge and counseling practices in the Eastern Province, Saudi Arabia: A cross-sectional study

Ahmed Adel Mohamed et al. J Pharm Bioallied Sci. 2020 Jul-Sep.

Abstract

Context: For several decades, warfarin has been considered the mainstay anticoagulant for patients who require long-term prevention or treatment of thromboembolic disorders in outpatient settings. Hospital and community pharmacists--with adequate knowledge level and counseling skills--can play a significant role in improving warfarin therapy.

Aims: The aim of this study was to assess the hospital and community pharmacists' warfarin therapy knowledge and counseling practices in the eastern province of Saudi Arabia.

Materials and methods: A cross-sectional study was conducted for 2 months. A self-administered questionnaire was designed focusing on warfarin mechanism of action, indications, safety profile, management of toxicity, monitoring, drug/food interactions, and patient education. The questionnaire was distributed among a random sample of hospital and community pharmacists in the Eastern Province of Saudi Arabia.

Results: One hundred and fifty-three pharmacists participated in the study; ninety-seven of them were hospital-based (63.4%), whereas the remaining were community pharmacists. Participant's mean years' of experience was 5.67. In terms of the percentage of right answers, hospital pharmacists showed significantly better warfarin therapy knowledge than community pharmacists (P = 0.026). The percentages of right answers were 31.3% for drug/food interactions, 49.9% for safety profile/management of toxicity, 53.3% for patient education, and 58.2% for monitoring warfarin safety/efficacy. Neither the participants' educational level nor their duration of experience had a significant correlation with the percentage of right answers (P = 0.22 and 0.61).

Conclusion: Inadequate knowledge and inappropriate practices were encountered among study participants, especially community pharmacists. Therefore, specialized training of pharmacists about warfarin therapy management is essential to optimize therapeutic outcomes and prevent complications.

Keywords: Anticoagulants; counseling; drug interactions; knowledge; pharmacists; warfarin.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Choi S, Douketis JD. Management of patients who are receiving warfarin or a new oral anticoagulant and require urgent or emergency surgery. Pol Arch Med Wewn. 2012;122:437–42. - PubMed
    1. Fihn SD. Aiming for safe anticoagulation. N Engl J Med. 1995;333:54–5. - PubMed
    1. Vranckx P, Valgimigli M, Heidbuchel H. The significance of drug–drug and drug–food interactions of oral anticoagulation. Arrhythmia Electrophysiol Rev. 2018;7:55. - PMC - PubMed
    1. QuarterWatch (2016 Annual Report) [Last accessed on 2018 Oct 6]. Part II: Oral Anticoagulants—The Nation’s Top Risk of Acute Injury from Drugs | Institute for Safe Medication Practices. [Online]. Available from: https://www.ismp.org/resources/quarterwatchtm-2016-annual-report-part-ii... .
    1. Wang SV, Franklin JM, Glynn RJ, Schneeweiss S, Eddings W, Gagne JJ. Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study. BMJ. 2016;353:i2607. - PMC - PubMed